Verici Dx plc (LON:VRCI – Get Free Report)’s share price dropped 0.3% during mid-day trading on Thursday . The stock traded as low as GBX 0.25 and last traded at GBX 0.30. 3,757,420 shares traded hands during mid-day trading, an increase of 116% from the average daily volume of 1,736,594 shares. The stock had previously closed at GBX 0.30.
Verici Dx Stock Performance
The stock has a market capitalization of £7.29 million, a price-to-earnings ratio of -0.27 and a beta of 1.26. The company has a debt-to-equity ratio of 3.03, a current ratio of 3.94 and a quick ratio of 8.49. The stock has a 50-day moving average of GBX 0.37 and a 200 day moving average of GBX 0.50.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Further Reading
- Five stocks we like better than Verici Dx
- MarketBeat Week in Review – 07/27- 07/31
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
